pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    mRNA-3927
    Propionic Acidemia$MRNA Moderna, Inc.
  • Phase 1
    mRNA-4106
    Cervical Cancer$MRNA Moderna, Inc.
  • Phase 2
    mRNA-4359
    Solid Tumor$MRNA Moderna, Inc.
  • Marketed
← prev
page 228 of 271
next →
Pain89
Neurology1
mafenide acetate
Sulfamylon (mafenide acetate)
Surgical Wound Infections
Mylan Pharmaceuticals Inc
  • Preclinical
    magnesium lysinate bis eicosapentaenoate
    magnesium lysinate bis eicosapentaenoate
    Pancreatic Cancer Thetis Pharmaceuticals LLC
  • Marketed
    magnesium sulfate Fresenius
    Magnesium Sulfate
    Pre-Eclampsia Fresenius Kabi USA LLC
  • Marketed
    magnesium sulfate Pfizer
    Magnesium Sulfate
    Seizures Hospira Inc
  • Phase 2
    malaria [strain NF-54] vaccine 2
    Malaria Sanaria Inc
  • Phase 1
    malaria vaccine 3
    Malaria PATH Malaria Vaccine Initiative
  • Marketed
    malathion
    Malathion
    Pediculosis capitis (Head Lice Infestation) Suven Life Sciences Ltd
  • Marketed
    mannitol
    Bronchitol (mannitol)
    Cystic Fibrosis Arna Pharma Pty Ltd
  • Marketed
    maralixibat chloride
    Livmarli (maralixibat chloride)
    Biliary Atresia$MIRM Mirum Pharmaceuticals, Inc.
  • Preclinical
    maraviroc
    Maraviroc (maraviroc [INN])
    Parkinson's Disease Forest Hills Partners Hong Kong Ltd
  • Phase 2
    margetuximab
    Margenza (margetuximab-cmkb)
    Gastric Cancer TerSera Therapeutics LLC
  • Marketed
    maribavir
    Livtencity (maribavir)
    Cytomegalovirus (HHV-5) Infections Takeda Pharmaceuticals USA Inc
  • Marketed
    marnetegragene autotemcel
    Kresladi (marnetegragene autotemcel)
    Leukocyte Disorders (White Blood Cell Disorders)$RCKT ROCKET PHARMACEUTICALS, INC.
  • Phase 3
    masitinib
    masitinib [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) AB Science SA
  • Phase 3
    masupirdine
    masupirdine [INN]
    Dementia Associated With Alzheimer's Disease Suven Life Sciences Ltd
  • Marketed
    mavacamten
    Camzyos (mavacamten)
    Hypertrophic Cardiomyopathy Bristol-Myers Squibb Co
  • Phase 2
    maveropepimut-s
    maveropepimut-s
    Fallopian Tube Cancer$BVAXF BioVaxys Technology Corp.
  • Marketed
    mavorixafor
    Xolremdi (mavorixafor)
    Neutropenia$XFOR X4 Pharmaceuticals, Inc
  • Phase 2
    mavrilimumab
    mavrilimumab
    Rheumatoid Arthritis MedImmune Ltd
  • Phase 2
    mavrostobart
    mavrostobart
    Solid Tumor Phanes Therapeutics Inc
  • Phase 2
    mazindol ER
    Quilience (mazindol)
    Idiopathic Hypersomnia (IH)$NCEL NewcelX Ltd.
  • Marketed
    mebendazole
    Emverm (mebendazole)
    Ancylostomiasis (Hookworm Infections)$AMRX Amneal Pharmaceuticals, Inc.
  • Phase 2
    mebufotenin
    mebufotenin [INN]
    Treatment Resistant Depression$ATAI AtaiBeckley Inc.
  • Marketed
    mecamylamine
    Mecamylamine Hydrochloride (mecamylamine [INN])
    Idiopathic (Essential) Hypertension Tilde Sciences LLC
  • Marketed
    mecasermin
    Increlex (mecasermin)
    Growth Disorders$ETON Eton Pharmaceuticals, Inc.
  • Phase 2
    mecasermin rinfabate
    mecasermin rinfabate
    Bronchopulmonary Dysplasia Chiesi Farmaceutici SpA
  • Phase 2
    mecbotamab vedotin
    mecbotamab vedotin
    Non-Small Cell Lung Cancer$BCAB BioAtla, Inc.